Brief: Tela Bio Announces Sale Of Distribution Rights For Wound Care Product To Mimedx
March 20 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO ANNOUNCES SALE OF DISTRIBUTION RIGHTS FOR WOUND
CARE
PRODUCT TO MIMEDX
* TELA BIO INC - AS CONSIDERATION FOR SALE, MIMEDX WILL MAKE
AN
INITIAL $5.0 MILLION PAYMENT
* TELA BIO- MIMEDX WILL MAKE FUTURE PAYMENTS BETWEEN
MINIMUM OF
$3.0 MILLION AND $7.0 MILLION BASED ON NET SALES OF NIVIS OVER
NEXT TWO YEARS
Source text for Eikon: ID:nGNXbYWJ87
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants